ERBB2 and neoplasm: A tumor marker, human epidermal growth factor receptor 2 (HER2), was the target of a sensitive label-free impedimetric biosensor developed by Ravalli et al. [68] The authors used in this case an affibody, a protein generated using a combinatorial protein engineering approach for the target analyte.